Jonathan Myers
CIK 1944597 · View on SEC EDGAR ↗
First SEC filing: Aug. 29, 2022 · Latest: March 3, 2025
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 1, 2025 | DBD | F | 1,586 | $44.23 | $70,149 | 38,770 Direct | -3.93% | Disposed | 52.4% (price as of 2026-08-20) |
| March 1, 2025 | DBD | A | 13,137 | — | — | 40,356 Direct | +48.26% | Acquired | (price as of 2026-08-20) |
| Jan. 19, 2025 | DBD | F | 1,101 | $44.49 | $48,983 | 27,219 Direct | -3.89% | Disposed | 51.5% (price as of 2026-08-20) |
| March 1, 2024 | DBD | A | 15,798 | — | — | 28,320 Direct | +126.16% | Acquired | (price as of 2026-08-20) |
| Jan. 19, 2024 | DBD | A | 62,610 | — | — | 62,610 Direct | — | Acquired | (price as of 2026-08-20) |
| Jan. 19, 2024 | DBD | A | 12,522 | — | — | 12,522 Direct | — | Acquired | (price as of 2026-08-20) |
| Aug. 11, 2023 | DBD | J | 200 | — | — | 0 Indirect | -100.00% | Disposed | (price as of 2026-08-20) |
| Aug. 11, 2023 | DBD | J | 107,804 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-20) |
| Jan. 31, 2023 | DBD | F | 19,100 | $2.39 | $45,649 | 107,804 Direct | -15.05% | Disposed | 2719.7% (price as of 2026-08-20) |
| Aug. 22, 2022 | DBD | A | 126,904 | — | — | 126,904 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 19, 2024 | DBD | Employee Stock Option (right to buy) | Common Stock (62,610) | $30.90 | Jan. 19, 2034 | 62,610 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 29, 2022 | DBD | Common Shares | 200 | Indirect |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
DBD
Chief Revenue Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $550,000 | — | $907,948 | $683,701 | $679,543 | — | $20,303 | $2,841,495 |
| 2023 | $550,000 | $700,000 | — | — | $455,141 | — | $28,918 | $1,734,059 |
| 2022 | — | — | — | — | — | — | — | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.